Log In
BCIQ
Print this Print this
 

MX-1520

  Manage Alerts
Collapse Summary General Information
Company Medinox Inc.
DescriptionProdrug of vanillin
Molecular Target Hemoglobin
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSickle cell disease
Indication DetailsTreat sickle cell anemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today